THE IMMUNOTHERAPEUTIC EFFECTS OF PENTOXIFYLLINE IN TYPE 1 DIABETIC MICE AND ITS EFFECTS ON EXPRESSIONS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARγ) GENE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MALEKIFAR F.; DELIREZH N.; HOBBENAGHI R.; MALEKINEJAD H.; SOLEIMANZADEH A.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Armaghane Danesh Year:2015 | Volume:20 | Issue:2 (97) Page(s): 103-113

Download Full-Text

Persian Verion

View:

610

Download:

Cites:

Information Journal Paper

Title

THE IMMUNOTHERAPEUTIC EFFECTS OF PENTOXIFYLLINE IN TYPE 1 DIABETIC MICE AND ITS EFFECTS ON EXPRESSIONS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARγ) GENE

Author(s)

Keywords

TYPE 1 DIABETESQ2

PENTOXIFYLLINEQ2

CYTOKINEQ2

PPAR γQ2

Abstract

Background & aim: PENTOXIFYLLINE is an immunomodulatory and anti-inflammatory agent which inhibits the production of proinflammatory CYTOKINEs. The purpose of this study was to evaluate the effect of PENTOXIFYLLINE in the treatment of TYPE 1 DIABETES in mice and its effect on the expression of peroxisome proliferator- activated receptor gamma (PPARg).Methods: After induction of diabetes in male C57BL/6 mice, they were treated with PENTOXIFYLLINE (100 mg/kg/day) for 21 days. Blood sugar levels were measured on days 0, 7, 14 and 21.Splenocytes were tested for CYTOKINEs production by ELISA. Further investigations on immune system changes in spleens were tested by semi-quantitative RT-PCR on PPARγ gene. Statistical data were analyzed using the Student t-test and ANOVA.Results: Treatment with PENTOXIFYLLINE prevented the level of blood sugar in diabetic rats.Pentoxifylline treatment also significantly inhibited the production of proinflammatory CYTOKINEs IL- 17 and IFN-g, while cause increasing the anti-inflammatory CYTOKINE IL- 10 and the expression of PPARg gene in the spleen compared to the diabetic control group (p<0.05).Conclusion: Due to STZ induction, PENTOXIFYLLINE may have therapeutic effects against autoimmune destruction of pancreatic beta cells on TYPE 1 DIABETES in mice.

Cites

No record.

References

No record.

Cite

APA: Copy

MALEKIFAR, F., DELIREZH, N., HOBBENAGHI, R., MALEKINEJAD, H., & SOLEIMANZADEH, A.. (2015). THE IMMUNOTHERAPEUTIC EFFECTS OF PENTOXIFYLLINE IN TYPE 1 DIABETIC MICE AND ITS EFFECTS ON EXPRESSIONS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARγ) GENE. ARMAGHAN DANESH, 20(2 (97)), 103-113. SID. https://sid.ir/paper/78102/en

Vancouver: Copy

MALEKIFAR F., DELIREZH N., HOBBENAGHI R., MALEKINEJAD H., SOLEIMANZADEH A.. THE IMMUNOTHERAPEUTIC EFFECTS OF PENTOXIFYLLINE IN TYPE 1 DIABETIC MICE AND ITS EFFECTS ON EXPRESSIONS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARγ) GENE. ARMAGHAN DANESH[Internet]. 2015;20(2 (97)):103-113. Available from: https://sid.ir/paper/78102/en

IEEE: Copy

F. MALEKIFAR, N. DELIREZH, R. HOBBENAGHI, H. MALEKINEJAD, and A. SOLEIMANZADEH, “THE IMMUNOTHERAPEUTIC EFFECTS OF PENTOXIFYLLINE IN TYPE 1 DIABETIC MICE AND ITS EFFECTS ON EXPRESSIONS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARγ) GENE,” ARMAGHAN DANESH, vol. 20, no. 2 (97), pp. 103–113, 2015, [Online]. Available: https://sid.ir/paper/78102/en

Related Journal Papers